GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Design Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DSGN)

Symbol: DSGN on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$6,375,975	679,590	-16,023	-2.3%	$9.38	Q4 2025
30 Sep 2025	0%	-0%	$5,239,165	695,613	-98,395	-12%	$7.53	Q3 2025
30 Jun 2025	0%	+0%	$2,676,302	794,008	+18,511	+2.4%	$3.37	Q2 2025
31 Mar 2025	0%	+0%	$2,994,107	775,497	+13,857		$3.86	Q1 2025
31 Dec 2024	0%	+0%	$4,700,416	761,640	+3,090	+0.41%	$6.17	Q4 2024
30 Sep 2024	0%	+0%	$4,081,319	758,550	+50,579	+7.1%	$5.38	Q3 2024
30 Jun 2024	0%	+0%	$2,371,911	707,971	+24,073	+3.5%	$3.35	Q2 2024
31 Mar 2024	0%	+0%	$2,756,350	683,898	+21,154	+3.2%	$4.03	Q1 2024
31 Dec 2023	0%	+0%	$1,756,417	662,744	+28,024	+4.4%	$2.65	Q4 2023
30 Sep 2023	0%	-0%	$1,498,082	634,720	-2,125	-0.33%	$2.36	Q3 2023
30 Jun 2023	0%	+0%	$4,012,123	636,845	+3,837	+0.61%	$6.30	Q2 2023
31 Mar 2023	0%	+0%	$3,652,456	633,008	+29,995	+5%	$5.77	Q1 2023
31 Dec 2022	0%	+0%	$6,186,000	603,013	+26,304	+4.6%	$10.26	Q4 2022
30 Sep 2022	0%	+0%	$9,642,000	576,709	+141,584	+33%	$16.72	Q3 2022
30 Jun 2022	0%	+0%	$6,091,000	435,125	+68,380	+19%	$14.00	Q2 2022
31 Mar 2022	0%	+0%	$5,922,000	366,745	+15,304	+4.4%	$16.15	Q1 2022
31 Dec 2021	0%	+0%	$7,524,000	351,441	+93,409	+36%	$21.41	Q4 2021
30 Sep 2021	0%	+0%	$3,790,000	258,032	+5,272	+2.1%	$14.69	Q3 2021
30 Jun 2021	0%	+0%	$5,027,000	252,760	+215,060	+570%	$19.89	Q2 2021
31 Mar 2021	0%	+0%	$1,127,000	37,700	+37,700	NEW	$29.89	Q1 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.